伴隨診斷市場按技術類型、應用、最終用戶和地區分類

Companion Diagnostics Market, By Technology Type, By Application, By End User, By Region

出版日期: 2025年12月24日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2025 年，伴隨診斷市場規模將達到 87.6 億美元，到 2032 年將達到 197.3 億美元，2025 年至 2032 年的複合年成長率為 12.3%。

報告內容		報告詳情
基準年：	2024	2025年市場規模：	87.6億美元
歷史數據時期：	2020年至2024年	預測期：	2025年至2032年
預測期（2025-2032年）複合年成長率：	12.30%	2032 年的預測值：	197.3億美元

伴隨診斷是一種用於檢測患者體內特定生物標記或基因的醫療設備，有助於確定哪些患者最適合接受特定治療方法。這些診斷在個人化醫療中發揮著重要作用，能夠幫助醫生為癌症和其他疾病選擇合適的標靶治療。伴隨診斷測試評估與患者對特定藥物的反應相關的生物標記（例如蛋白質、基因或染色體）的表達量。分析這些生物標記的表達量有助於確定特定藥物對特定患者或患有特定疾病的患者群體是否安全有效。這確保了只有合適的患者才能接受專門治療，從而改善治療效果。

市場動態

全球伴隨診斷市場的發展動力主要來自對個人化醫療日益成長的需求、分子診斷技術的進步、新型標靶治療和伴隨診斷核准的增加、技術進步以及癌症和其他慢性疾病發生率和盛行率的上升。然而，與這些分子診斷測試的開發和商業化相關的高定價壓力和複雜的監管問題可能會阻礙因素市場成長。此市場的主要機會包括：開發用於免疫療法的生物標記和伴隨診斷；拓展在非腫瘤疾病領域的應用；體外診斷（IVD）公司與製藥公司在精準醫療領域的合作；新興市場對伴隨診斷開發的日益重視；以及採用次世代定序（NGS）等先進技術進行生物標記檢測。

本次調查的主要特點

本報告對全球伴隨診斷市場進行了詳細分析，以 2024 年為基準年，給出了 2025 年至 2032 年的市場規模（十億美元）和復合年成長率（%）。
它還重點介紹了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本報告根據以下參數對全球伴隨診斷市場的主要企業參與者進行了分析：公司概況、產品系列、主要亮點、財務績效和策略。
本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球伴隨診斷市場報告涵蓋了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過各種用於分析全球伴隨診斷市場的策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

公司簡介
- F.Hoffmann-La Roche AG
- Agilent Technologies, Inc
- QIAGEN NV
- Abbott Laboratories, Inc.
- Almac Group
- Danaher Corporation
- Illumina, Inc
- bioMerieux SA
- Myriad Genetics, Inc
- Sysmex Corporation
- Thermo Fisher Scientific Inc
- Abnova Corporation
- Guardant Health, Inc.
- Icon Plc
- Biogenex Laboratories, Inc

第9章各節

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI109

Companion Diagnostics Market is estimated to be valued at USD 8.76 Bn in 2025 and is expected to reach USD 19.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 8.76 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.30%	2032 Value Projection:	USD 19.73 Bn

Companion diagnostics are medical devices that are used to detect specific biomarkers or genes in patients that help determine which patients are most suitable candidates for a particular therapy. These diagnostics play an important role in personalized healthcare by helping physicians select appropriate targeted treatment options for cancer and other diseases. Companion diagnostics tests evaluate the expression of biomarkers, such as proteins, genes or chromosomes that plays a role in a patient's response to a specific drug. By analyzing the expression levels of such biomarkers, these tests help to identify whether a particular drug would be safe and effective for a specific patient or set of patients with a given disease. This enables better therapeutic outcomes by ensuring only suitable patients receive specialized treatments.

Market Dynamics

Global companion diagnostics market is driven by rising demand for personalized medicine, growth in molecular diagnostics, increasing approvals of new targeted therapies & companion diagnostics, technological advancements, and growing incidence and prevalence of cancer, and other chronic diseases. However, the market growth can be restricted by high pricing pressure and regulatory hassles that are involved in developing and commercializing these molecular diagnostic tests. Key opportunities in this market include developing biomarkers and companion diagnostics for immunotherapies, expanding applications in non-oncology diseases, precision medicine collaborations between In vitro diagnostics (IVD) companies and drug makers, growing focus on companion diagnostic development in emerging markets, and adoption of advanced technologies like Next-generation sequencing (NGS) for biomarker detection.

Key features of the study

This report provides in-depth analysis of the global companion diagnostics market, and provides market size (USD Bn)and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global companion diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche AG, Agilent Technologies, Inc., QIAGEN N.V, Abbott Laboratories, Inc., Almac Group, Danaher Corporation, Illumina, Inc., bioMerieux SA, Myriad Genetics, Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., Abnova Corporation, Guardant Health, Inc., Icon Plc., and Biogenex Laboratories, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global companion diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global companion diagnostics market

Market Segmentation

By Technology Type
- Real Time-Polymerase Chain Reactions (PCR)
- Gene Sequencing
- Fluorescence in situ Hybridization
- Others
By Application
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
- Neurological Diseases
- Others
By End User
- Hospitals
- Research Laboratories
- Biopharmaceutical companies
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Hoffmann-La Roche AG
- Agilent Technologies, Inc
- QIAGEN N.V
- Abbott Laboratories, Inc.
- Almac Group
- Danaher Corporation
- Illumina, Inc.
- bioMerieux SA
- Myriad Genetics, Inc.
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Abnova Corporation
- Guardant Health, Inc.
- Icon Plc.,
- Biogenex Laboratories, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Technology Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing number of cancer patients
- Complexity of Integration
- Emerging markets
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions and Collaborations

4. Global Companion Diagnostics Market, By Technology Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Real Time-Polymerase Chain Reactions (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gene Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Fluorescence in situ Hybridization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Companion Diagnostics Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurological Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Companion Diagnostics Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biopharmaceutical companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Companion Diagnostics Market, By Region, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Company Profiles
- F.Hoffmann-La Roche AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Agilent Technologies, Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- QIAGEN N.V
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Abbott Laboratories, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Almac Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Danaher Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Illumina, Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- bioMerieux SA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Myriad Genetics, Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sysmex Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Thermo Fisher Scientific Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Abnova Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Guardant Health, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Icon Plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Biogenex Laboratories, Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
  - Analysts' Views